Obstructive sleep apnea (OSA) exposes the cardiovascular system to intermittent hypoxia,
oxidative stress, systemic inflammation, exaggerated negative intrathoracic pressure …

Central sleep apnea is a devastating disease which occurs in approximately 40% of patients
with heart failure as well as patients with a history of stroke, opioid use and neurological …

Aims To determine whether severity patterns or nocturnal ventilation to treat sleep‐
disordered breathing (SDB) during chronic heart failure (CHF) is associated with adverse …

Central apnea is due to temporary failure in breathing rhythm generation resulting in the loss
of ventilatory effort, lasting at least 10 seconds. During central apnea, there is no medullary …

Sleep apnoea is associated with significant daytime functioning impairment and marked
cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic …

Sleep-related breathing disorders are highly prevalent in patients with established
cardiovascular disease. Obstructive sleep apnea (OSA) affects an estimated 15 million adult …

Background Whether there is an association between sleep apnea (SA) and the risk of
developing heart failure (HF) is unclear. Furthermore, it has never been established whether …

Background Obstructive sleep apnea (OSA) is common in heart failure (HF) patients and
exacerbates the outcome of this chronic disease. However, the frequency of HF arising from …

Sleep disordered breathing (SDB) is a common problem with adverse cardiorespiratory,
endocrinological, and endothelial effects. Recent studies demonstrate an even higher …

Neurophysiologically, central sleep apnea (CSA) is due to a temporary failure of respiratory
rhythmogenesis. CSA occurs in a number of disorders across all age groups and both …